Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- Check6 days agoChange DetectedThe site footer's revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1. The study record content remains unchanged.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.7.0 was added to the study record history, replacing the previous Revision: v3.6.6, signaling an updated version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check55 days agoChange DetectedThe record history page shows a new revision label v3.6.6 replacing the previous v3.6.5, indicating a deployment update rather than a change to the study information.SummaryDifference0.1%

- Check77 days agoChange DetectedThe study record history now includes a new revision entry for v3.6.5, replacing the previous revision v3.6.4, indicating a platform update to the page.SummaryDifference0.1%

- Check91 days agoChange DetectedThe page history shows a revision update from v3.6.3 to v3.6.4, indicating a small platform change to the study record page. No study data or content appears to be altered.SummaryDifference0.1%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.